13,180.00
+470(+3.70%)
Currency In KRW
Address
Bomnal-A-Chim B/D
Seoul,
Korea, Republic of
Phone
82 2 572 6675
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
323
First IPO Date
January 24, 2017
| Name | Title | Pay | Year Born |
| Tae-Young Heo | Chief Executive Officer & Head of Management Administration | 0 | N/A |
| Mr. Yeong-Ok Baik | Chief Executive Officer & Head of Production, Quality, and R&D | 0 | N/A |
| Mr. Kyeong-Ho Min | Vice President & Head of Production | 0 | 1968 |
| Mr. Chan-kyu Lee | Vice President & Head of Research and Development | 0 | N/A |
EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant biological products and antibody therapeutics. In addition, the company offers process, formulation, and analytical method development, as well as licensing consulting services; and contract testing services that include lot release, stability, raw material, and method validation testing services. The company was founded in 2010 and is based in Seoul, South Korea.